Editor's Choice - International Variations and Sex Disparities in the Treatment of Peripheral Arterial Occlusive Disease: A Report from VASCUNET and the International Consortium of Vascular Registries.
Age Factors
Aged
Aged, 80 and over
Australia
Europe
Female
Healthcare Disparities
/ statistics & numerical data
Humans
Intermittent Claudication
/ etiology
Internationality
Length of Stay
/ statistics & numerical data
Male
New Zealand
Patient Selection
Peripheral Arterial Disease
/ complications
Registries
Sex Factors
United States
Vascular Surgical Procedures
/ statistics & numerical data
Administrative data
Diabetic foot syndrome (DFS)
Epidemiology
Lower extremity artery disease
Peripheral arterial occlusive disease (PAOD)
Registries
Journal
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
20
05
2020
revised:
30
06
2020
accepted:
17
08
2020
pubmed:
3
10
2020
medline:
10
2
2021
entrez:
2
10
2020
Statut:
ppublish
Résumé
The aim of this study was to determine sex specific differences in the invasive treatment of symptomatic peripheral arterial occlusive disease (PAOD) between member states participating in the VASCUNET and International Consortium of Vascular Registries. Data on open surgical revascularisation and peripheral vascular intervention (PVI) of symptomatic PAOD from 2010 to 2017 were collected from population based administrative and registry data from 11 countries. Differences in age, sex, indication, and invasive treatment modality were analysed. Data from 11 countries covering 671 million inhabitants and 1 164 497 hospitalisations (40% women, mean age 72 years, 49% with intermittent claudication, 54% treated with PVI) in Europe (including Russia), North America, Australia, and New Zealand were included. Patient selection and treatment modality varied widely for the proportion of female patients (23% in Portugal and 46% in Sweden), the proportion of patients with claudication (6% in Italy and 69% in Russia), patients' mean age (70 years in the USA and 76 years in Italy), the proportion of octogenarians (8% in Russia and 33% in Sweden), and the proportion of PVI (24% in Russia and 88% in Italy). Numerous differences between females and males were observed in regard to patient age (72 vs. 70 years), the proportion of octogenarians (28% vs. 15%), proportion of patients with claudication (45% vs. 51%), proportion of PVI (57% vs. 51%), and length of hospital stay (7 days vs. 6 days). Remarkable differences regarding the proportion of peripheral vascular interventions, patients with claudication, and octogenarians were seen across countries and sexes. Future studies should address the underlying reasons for this, including the impact of national societal guidelines, reimbursement, and differences in health maintenance.
Identifiants
pubmed: 33004283
pii: S1078-5884(20)30726-7
doi: 10.1016/j.ejvs.2020.08.027
pmc: PMC8080993
mid: NIHMS1694661
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
873-880Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL150290
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.
Références
Circulation. 2012 Mar 20;125(11):1449-72
pubmed: 22343782
J Vasc Surg. 2018 Jan;67(1):206-216.e2
pubmed: 28844467
Am Surg. 2018 Jun 1;84(6):1069-1078
pubmed: 29981651
Lancet. 2013 Oct 19;382(9901):1329-40
pubmed: 23915883
Eur J Vasc Endovasc Surg. 2018 Aug;56(2):217-237
pubmed: 29776646
Circulation. 2016 Dec 13;134(24):1948-1958
pubmed: 27784712
J Intern Med. 2020 Jul;288(1):51-61
pubmed: 32303118
Br J Surg. 2000 Mar;87(3):328-37
pubmed: 10718803
Eur J Vasc Endovasc Surg. 2012 Aug;44(2):185-92
pubmed: 22658613
J Vasc Surg. 2010 Feb;51(2):372-8.e1; discussion 378-9
pubmed: 20022204
Eur J Vasc Endovasc Surg. 2019 Jun;57(6):816-821
pubmed: 31128987
Gesundheitswesen. 2015 Feb;77(2):120-6
pubmed: 25622207
J Am Coll Cardiol. 2018 Aug 28;72(9):999-1011
pubmed: 30139446
Eur J Vasc Endovasc Surg. 2020 Sep;60(3):421-429
pubmed: 32669223
J Am Coll Cardiol. 2017 Mar 21;69(11):e71-e126
pubmed: 27851992
Circ Cardiovasc Interv. 2018 Jan;11(1):e005749
pubmed: 29326151
Eur J Vasc Endovasc Surg. 2019 May;57(5):658-665
pubmed: 30902607
J Vasc Surg. 2016 Oct;64(4):1009-1017.e3
pubmed: 27209402
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33
pubmed: 31182334
Eur J Prev Cardiol. 2021 Oct 25;28(13):1426-1434
pubmed: 34695221
Eur J Vasc Endovasc Surg. 2018 Sep;56(3):391-399
pubmed: 29859821
Eur J Vasc Endovasc Surg. 2020 Jan;59(1):59-66
pubmed: 31744786
Eur J Vasc Endovasc Surg. 2012 Aug;44(2):193-4
pubmed: 22626990
Eur J Vasc Endovasc Surg. 2019 Dec;58(6):792-793
pubmed: 31422049
JAMA. 2007 Mar 21;297(11):1197-206
pubmed: 17374814
Eur J Vasc Endovasc Surg. 2017 Apr;53(4):511-519
pubmed: 28274551
J Am Heart Assoc. 2019 Sep 3;8(17):e013088
pubmed: 31475624
Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368
pubmed: 28851596